Search research articles
Contact Us
Filters
Showing results (1-10 of 62) with videos related to
Page
of 7
Sort By:
Bioorganic & Medicinal Chemistry
|
April 10, 2007
Improved biochemical strategies for targeted delivery of taxoids
Thota Ganesh
Journal of Medicinal Chemistry
|
July 17, 2023
Targeting EP2 Receptor for Drug Discovery: Strengths, Weaknesses, Opportunities, and Threats (SWOT) Analysis
Thota Ganesh
Journal of Medicinal Chemistry
|
November 28, 2013
Prostanoid receptor EP2 as a therapeutic target
Thota Ganesh
Expert Opinion on Therapeutic Patents
|
March 17, 2015
Evaluation of WO 2012/177618 A1 and US-2014/0179750 A1: novel small molecule antagonists of prostaglandin-E2 receptor EP2
Thota Ganesh
European Journal of Medicinal Chemistry
|
June 18, 2014
Development of second generation EP2 antagonists with high selectivity
Thota Ganesh, Jianxiong Jiang, Ray Dingledine
Bioorganic & Medicinal Chemistry
|
November 8, 2020
Azaindole therapeutic agents
Damoder Reddy Motati, Radhika Amaradhi, Thota Ganesh
Neuropharmacology
|
December 16, 2019
Modulating neuroinflammation and oxidative stress to prevent epilepsy and improve outcomes after traumatic brain injury
Clifford L Eastman, Raimondo D'Ambrosio, Thota Ganesh
Brain, Behavior, & Immunity - Health
|
September 30, 2021
Inhibition of the prostaglandin EP2 receptor prevents long-term cognitive impairment in a model of systemic inflammation
Chunxiang Jiang, Aysegul Caskurlu, Thota Ganesh, et al.
ACS Chemical Neuroscience
|
January 4, 2017
Ethylatropine Bromide as a Peripherally Restricted Muscarinic Antagonist
Asheebo Rojas, Thota Ganesh, Alec Walker, et al.
ACS Medicinal Chemistry Letters
|
August 6, 2013
Discovery and characterization of carbamothioylacrylamides as EP<sub>2</sub> selective antagonists
Thota Ganesh, Jianxiong Jiang, Rangaiah Shashidharamurthy, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 62) with videos related to
Sort By:
Page
of 7
Bioorganic & Medicinal Chemistry
|
April 10, 2007
Improved biochemical strategies for targeted delivery of taxoids
Thota Ganesh
Journal of Medicinal Chemistry
|
July 17, 2023
Targeting EP2 Receptor for Drug Discovery: Strengths, Weaknesses, Opportunities, and Threats (SWOT) Analysis
Thota Ganesh
Journal of Medicinal Chemistry
|
November 28, 2013
Prostanoid receptor EP2 as a therapeutic target
Thota Ganesh
Expert Opinion on Therapeutic Patents
|
March 17, 2015
Evaluation of WO 2012/177618 A1 and US-2014/0179750 A1: novel small molecule antagonists of prostaglandin-E2 receptor EP2
Thota Ganesh
European Journal of Medicinal Chemistry
|
June 18, 2014
Development of second generation EP2 antagonists with high selectivity
Thota Ganesh, Jianxiong Jiang, Ray Dingledine
Bioorganic & Medicinal Chemistry
|
November 8, 2020
Azaindole therapeutic agents
Damoder Reddy Motati, Radhika Amaradhi, Thota Ganesh
Neuropharmacology
|
December 16, 2019
Modulating neuroinflammation and oxidative stress to prevent epilepsy and improve outcomes after traumatic brain injury
Clifford L Eastman, Raimondo D'Ambrosio, Thota Ganesh
Brain, Behavior, & Immunity - Health
|
September 30, 2021
Inhibition of the prostaglandin EP2 receptor prevents long-term cognitive impairment in a model of systemic inflammation
Chunxiang Jiang, Aysegul Caskurlu, Thota Ganesh, et al.
ACS Chemical Neuroscience
|
January 4, 2017
Ethylatropine Bromide as a Peripherally Restricted Muscarinic Antagonist
Asheebo Rojas, Thota Ganesh, Alec Walker, et al.
ACS Medicinal Chemistry Letters
|
August 6, 2013
Discovery and characterization of carbamothioylacrylamides as EP<sub>2</sub> selective antagonists
Thota Ganesh, Jianxiong Jiang, Rangaiah Shashidharamurthy, et al.
Page
of 7